Comparison of Iron Sucrose Complex Versus Ferric Carboxymaltose for Establishment of Effective Breastfeeding: A Quasi-Experimental Study

  • Aisha Malik Professor obs and gynae Fatima jinnah medical  university/sir ganagraam hospital lahore
  • Mahham Janjua Associate professor obstetric &GynaecologyFatima jinnah medical university/sir ganagraam 
  • Quratulain Shahzad Assistant professor obstetric &Gynaecology Akhtar saeed medical and.dental college 
  • Yasmin Sattar Consultant obstetric &Gynaecology Fatima jinnah medical university/sirgangaraam 
Keywords: Breastfeeding, Ferric carboxymaltose

Abstract

Objectives: To compare iron sucrose complex (ISC) versus ferric carboxymaltose (FCM) for establishment of effective breastfeeding

Methodology: This quasi-experimental study was conducted at Sir Ganga Ram Hospital Lahore from January to April 2025. Total 70 pregnant women with moderate-severe iron deficiency anemia were assigned, without randomization, into two equal size groups i.e. ISC and FCM. Baseline data were collected upon enrollment and outcome data at day-21 after intervention. Mann-Whitney U test used for comparing median (IQR), and Chi square test for frequency (percentage) between ISC and FCM groups. Linear regression analyses performed for neonatal weight gain and lactation initiation time; and multivariate binary logistic regression analyses for lactation adequacy.

Results: The distribution of baseline demographic and obstetric characteristics across study groups was equivalent (all p >0.05). At the day-21 follow-up, the ISC group, compared to the FCM group, showed less improvement in hemoglobin levels (0.8 vs. 1.9 g/dL, p <0.001) and serum ferritin (19.0 vs. 21.5 ng/mL, p 0.780). The ISC group also experienced a longer time to initiate breastfeeding (20 vs. 9 hours, p <0.001), but demonstrated higher lactation sufficiency (59.0% vs. 41.0%, p 0.072) and greater neonatal weight gain (680 vs. 31 grams, p <0.001). Being in FCM group showed negative association with neonatal weight gain (β -321.251, p <0.001) early breastfeeding initiation (β -8.396, p 0.004) and greater risk of lactation insufficiency (aOR 5.593, p 0.050).

Conclusion: Both ISC and FCM treatments offer unique benefits. FCM was better at improving maternal hemoglobin levels, while ISC showed advantages in terms of neonatal growth and early breastfeeding initiation. Therefore, selection of treatment should consider both maternal hematologic goals and neonatal well-being.

Keywords: Breastfeeding, Ferric carboxymaltose, Iron sucrose, Pregnancy

Author Biography

Yasmin Sattar, Consultant obstetric &Gynaecology Fatima jinnah medical university/sirgangaraam 

 

 

Published
2025-07-15
Section
Original Articles